Secondary forms of thrombotic microangiopathies, which occur in the context of pregnancy, autoimmune disease, malignancy, bone marrow transplantation or use of certain medications, are associated with mildly reduced or even normal ADAMTS13 activity [21–23]. Here, ADAMTS13 is linked to Genetic thrombotic microangiopathy.